National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 1) (PB 2 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00039

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 2 of 2015
 
National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 1)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated 12th January 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 1).
(2)                This Instrument may also be cited as PB 2 of 2015.
2              Commencement                                                        
                This instrument commences on 1 February 2015.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 4, entry for Carmellose
omit from the column headed “Form (strength, type, size, etc.)”:

 
Mouth spray containing carmellose sodium 10 mg per mL, 25 mL

 
Mouth spray containing carmellose sodium 10 mg per mL, 100 mL

[2]        Schedule 4, entry for Hypromellose
omit from the column headed “Form (strength, type, size, etc.)”:
 
Oral gel 20 mg per g, 100 g
[3]        Schedule 4, after entry for Miconazole in the form Tincture 20 mg per mL, 30 mL
insert:
Mifepristone and misoprostol
Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms